"10.1371_journal.pmed.1000375","plos medicine","2010-12-07T00:00:00Z","Thomas Land; Nancy A Rigotti; Douglas E Levy; Mark Paskowsky; Donna Warner; Jo-Ann Kwass; LeAnn Wetherell; Lois Keithly","Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America; Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Mongan Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Office of Medicaid Commonwealth of Massachusetts, Boston, Massachusetts, United States of America","ICMJE criteria for authorship read and met: TL NAR DEL MP DW JAK LW LK. Agree with the manuscripts results and conclusions: TL NAR DEL MP DW JAK LW LK. Designed the experiments/the study: TL DEL DW JAK LK. Analyzed the data: TL DEL MP LW. Collected data/did experiments for the study: TL MP LW. Wrote the first draft of the paper: TL. Contributed to the writing of the paper: NAR DEL DW JAK LW LK. Advised on design and analysis plan: NAR. Oversaw study design, contributed to implementation, and oversaw evaluation of MassHealth benefit: LK.","In the past 5 years, NARs institution has received research grant funding from Pfizer and Nabi Biopharmaceuticals for the study of investigational and/or marketed smoking cessation products. She has consulted for Pfizer and Free & Clear. She does not accept payment for consultation and has not for the past two years.","2010","12","Thomas Land","TL",8,TRUE,NA,NA,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
